Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Fund News: Rock Creek Group, Golub Capital, Forex Schemes

Massachusetts Charges Two Firms in Forex Schemes (WSJ)
Massachusetts’s securities regulator charged two unregistered offshore firms for alleged foreign-exchange investment scams. One of the cases involves allegations against two individuals who were sanctioned by the Securities and Exchange Commission for an alleged $34 million hedge fund investing fraud involving 60 investors in 2007.

Credit Suisse Group AG (ADR) (NYSE:CS)

Credit Suisse Eyes Fund Of Funds Rock Creek (FinAlternatives)
Credit Suisse Group is poised to buy fund of hedge funds Rock Creek Group. The two sides are in advanced talks and a deal could come within 10 days, AR magazine reports. A deal for Rock Creek would give Credit Suisse a substantial institutional fund of funds business. The Swiss bank’s current fund of funds business, which has about $10 billion in assets under management, specializes in high-net worth clients, especially those who already patronize Credit Suisse’s private bank.

U. Michigan Adds Hedge Fund Golub To Portfolio (FinAlternatives)
The University of Michigan’s endowment has invested $25 million in hedge fund Golub Capital. The initial investment in Golub’s Premium Earnings Adjustable Rate Loans (Pearls) Direct Lending Program “will further balance the university’s investment pool for working capital risk exposures and enhance returns by decreasing exposure to movements in interest rates and increasing exposures to corporate credit and investment manager value added,” Timothy Slottow, chief investment officer of the $6.6 billion pension, said in an internal memo.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!